These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1717034)

  • 21. [Hepatitis C].
    Viola LA; Fernández JL
    Acta Gastroenterol Latinoam; 1992; 22(2):133-4. PubMed ID: 1338677
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatitis C virus antibody in patients with chronic autoimmune hepatitis: pitfalls in diagnosis and implications for treatment.
    Davis GL
    Mayo Clin Proc; 1991 Jun; 66(6):647-50. PubMed ID: 1646354
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hepatitis C; current developments in diagnosis and therapy].
    Willems M; Moshage H; Fevery J; Yap SH
    Ned Tijdschr Geneeskd; 1992 Dec; 136(52):2564-7. PubMed ID: 1282675
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical evaluation of a newly established anti-HCV assay for the diagnosis of hepatitis C in Japan.
    Ishiguro N; Tomimatsu M; Nagahara H; Obata H
    J Gastroenterol Hepatol; 1992; 7(6):602-7. PubMed ID: 1283084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti GOR and hepatitis c virus in autoimmune liver disease.
    Garg P
    Trop Gastroenterol; 1992; 13(3):120-1. PubMed ID: 1336907
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-hepatitis C virus screening will reduce the incidence of post-transfusion hepatitis C also in low-risk areas.
    Mathiesen UL; Ekermo B; Foberg U; Franzén L; Frydén A; Norlin R; Pettersson LG; Sterling H; Widell A; Bodemar G
    Scand J Gastroenterol; 1992 Jun; 27(6):443-8. PubMed ID: 1321487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis-C virus (HCV) in peritoneal dialysis.
    Krautzig S; Tillmann H; Wrenger E; Manns M; Koch KM; Brunkhorst R
    Clin Nephrol; 1994 Feb; 41(2):120. PubMed ID: 7516274
    [No Abstract]   [Full Text] [Related]  

  • 28. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
    Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
    Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reactivation of hepatitis B virus infection induced by interferon (IFN) in HBsAg-positive, antiHCV-positive patients.
    Villa E; Grottola A; Trande P; Seium Y; Rebecchi AM; Dugani A; Manenti F
    Lancet; 1993 May; 341(8857):1413. PubMed ID: 7684479
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibodies to hepatitis C virus in Cuban blood donors.
    Rivero RA; Hedalgo-Gato R; Martinez M; Hernandez P; Ballester JM; Yamaguchi K; Fukuyoshi Y; Kiyokawa T; Takatsuki K
    Vox Sang; 1992; 63(4):285-6. PubMed ID: 1282758
    [No Abstract]   [Full Text] [Related]  

  • 31. [Seroprevalence of hepatitis C virus antibodies in obstetric patients at the Nuevo Hospital Civil de Guadalajara].
    Gamboa R; Gaxiola Castro R; Guana Flores R; Silva Maciel CA; Becerra Leyva G
    Ginecol Obstet Mex; 1994 Dec; 62():399-402. PubMed ID: 7530675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus antibody in Poland.
    Laskus T; Radkowski M; Lupa E; Cianciara J; Slusarczyk J; Halama G; Horban A
    Scand J Infect Dis; 1991; 23(3):385-6. PubMed ID: 1715607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-transfusion hepatitis C virus infection.
    Kleinman S; Busch M; Holland P
    N Engl J Med; 1992 Nov; 327(22):1601-2. PubMed ID: 1279422
    [No Abstract]   [Full Text] [Related]  

  • 34. Changes in antibodies to specific hepatitis C virus antigens with interferon-alpha therapy: analysis by recombinant immunoblot assay.
    Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
    Am J Gastroenterol; 1993 Jun; 88(6):914-8. PubMed ID: 7684885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-A, non-B hepatitis: impact of the emergence of the hepatitis C virus.
    Hsia PC; Seeff LB
    Adv Intern Med; 1992; 37():197-222. PubMed ID: 1313633
    [No Abstract]   [Full Text] [Related]  

  • 36. Antibodies to hepatitis C virus in people from Yucatan, Mexico.
    Góngora-Biachi RA; González-Martínez P; Puerto FI; Yamaguchi K; Nishimura Y; Takatsuki K
    Rev Invest Clin; 1992; 44(2):284. PubMed ID: 1332170
    [No Abstract]   [Full Text] [Related]  

  • 37. Recurrence of hepatitis C following liver transplantation: treatment with interferon.
    Van Thiel DH; Fagiuoli S; Caraceni P; Nadir A; Wright HI
    Transplant Sci; 1994 Dec; 4 Suppl 1():S26-8. PubMed ID: 7542986
    [No Abstract]   [Full Text] [Related]  

  • 38. High incidence of hepatitis C virus antibodies in hemodialysis patients.
    Machida J; Yamaguchi K; Ueda S; Yoshida M; Kusumoto Y; Nishimura Y; Futami G; Ishii T; Watanabe T; Takatsuki K
    Nephron; 1992; 60(1):117-8. PubMed ID: 1310800
    [No Abstract]   [Full Text] [Related]  

  • 39. Enzyme immunoassay of serum type IV collagen in anti-HCV positive chronic liver diseases.
    Matsuzaki Y; Yoshiga S; Sugitani T; Shoda J; Tanaka N; Osuga T
    Clin Chim Acta; 1993 Nov; 221(1-2):209-17. PubMed ID: 7512002
    [No Abstract]   [Full Text] [Related]  

  • 40. Epidemiology and long term prognosis of hepatitis C virus infection in Japan.
    Yano M; Yatsuhashi H; Inoue O; Inokuchi K; Koga M
    Gut; 1993; 34(2 Suppl):S13-6. PubMed ID: 7686112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.